Oral anticoagulants in fragile patients with percutaneous endoscopic gastrostomy and atrial fibrillation: the ORIGAMI pilot investigation-Reference-Cited by-同舟云学术

Oral anticoagulants in fragile patients with percutaneous endoscopic gastrostomy and atrial fibrillation: the ORIGAMI pilot investigation

Published:2023-02 Issue:1 Volume:71 Page:
ISSN:2724-5683
Container-title:Minerva Cardiology and Angiology
language:
Short-container-title:Minerva Cardiol Angiol

Author:

D’AMARIO Domenico,GALLI Mattia,CAPPANNOLI Luigi,CANONICO Francesco,RESTIVO Attilio,ARCUDI Alessandra,SCACCIAVILLANI Roberto,RICCIONI Maria E.,VERGALLO Rocco,MONTONE Rocco A.,CONTE Amelia,MELEO Emiliana,LANCELLOTTI Stefano,SACCO Monica,ANTONELLI Massimo,ANDREOTTI Felicita,DE CRISTOFARO Raimondo,CREA Filippo

Publisher

Edizioni Minerva Medica

Subject

Cardiology and Cardiovascular Medicine

Link

https://www.minervamedica.it/pdf.php?cod=R05Y2023N01A0109

Reference25 articles.

1. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

2. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

3. Consensus Statement; ESPEN guidelines on Artificial enteral nutrition - percutaneous endoscopic gastrostomy (PEG)

4. Percutaneous endoscopic gastrostomy in children less than 10 kilograms: A comparative study

5. Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility, effectiveness, and safety of edoxaban administration through percutaneous endoscopic gastrostomy: 12-months follow up of the ORIGAMI study;Frontiers in Cardiovascular Medicine;2022-12-22

2. Net clinical benefit of anticoagulant therapy from a neurologist's perspective: A review;Consilium Medicum;2022-02-15